Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Actuate Therapeutics, Inc (NASDAQ:ACTU) is set to IPO on July 24 on the NASDAQ exchange with shares priced between $8.00 and $10.00. The company focuses on developing cancer therapies and has an insider lock-up period of 180 days ending on January 20, 2025.
July 23, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Actuate Therapeutics, Inc (NASDAQ:ACTU) is set to IPO on July 24 with shares priced between $8.00 and $10.00. The company focuses on developing cancer therapies and has an insider lock-up period of 180 days ending on January 20, 2025.
The IPO of Actuate Therapeutics, Inc is likely to generate significant interest given its focus on cancer therapies, a high-impact area in biopharmaceuticals. The pricing range and the insider lock-up period are standard for IPOs, but the company's focus could attract strong initial demand.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100